Longeveron Issues Letter to Stockholders

Stock Information for Longeveron Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Longeveron Inc.

Longeveron® to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025
Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025
Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer's Disease
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B(TM)) in Alzheimer's Disease
Longeveron® to Present at the 37th Annual Roth Conference
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.